Drug Profile
GBP 411
Alternative Names: GBP411Latest Information Update: 28 May 2020
Price :
$50
*
At a glance
- Originator SK Chemicals
- Developer SK Bioscience
- Class Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pneumococcal infections
Most Recent Events
- 28 May 2020 No recent reports of development identified for clinical-Phase-Unknown development in Pneumococcal-infections(Prevention) in South Korea (IM, Injection)
- 02 Jul 2018 SK Chemicals divested the vaccine business portfolio to a newly formed subsidiary SK Bioscience
- 06 Jun 2017 SK Chemicals plans a phase II trial for Pneumococcal infections (Prevention, In infants, In volunteers) in Thailand (TCTR20170109002)